Subscribe To
Kyowa kirin to acquire orchard therapeutics for $478 mln
Japanese pharmaceutical firm Kyowa Kirin said on Thursday it would acquire Britain-based bio...
October 5, 2023, 4:36 am
Why shares of conduit pharmaceuticals are jumping wednesday
Conduit just began trading on the Nasdaq on Sept. 25. The company focuses on advancing other pharmaceutical...
October 4, 2023, 12:07 pm
Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...
October 4, 2023, 11:30 am
Is haemonetics (hae) stock outpacing its medical peers this year?
Here is how Haemonetics (HAE) and Amneal pharmaceuticals (AMRX) have performed compared to their sector...
October 4, 2023, 11:17 am
Eton pharmaceuticals announces acquisition of fda-approved ultra-rare disease product nitisinone
— Expect Q1 2024 product launch —— Nitisinone market estimated to be more than $50 million annually —— Eton will offer Eton Cares support pr...
October 4, 2023, 10:50 am
Eagle pharmaceuticals awarded first prize for poster to be presented at the international society for anaesthetic pharmacology 32nd annual meeting
— Study reports on an interim analysis of the pharmacokinetics and pharmacodynamics of remimazolam and a subsequent model-based optimization of the ...
October 4, 2023, 10:50 am
2 ai stocks that aren't worth the hype
Shares of Recursion pharmaceuticals and C3.ai spiked this year due to AI. Both business are unprofitabl...
October 4, 2023, 9:15 am
Teva partnership with sanofi ‘will pay dividends,' analyst says
Teva pharmaceutical Industries Ltd.'s TEVA, -4.10% new collaboration with Sanofi SNY, on an inflammator...
October 4, 2023, 8:50 am
Eli lilly exec behind diabetes blockbuster set retire
Mike Mason, the executive vice president and president of Lilly Diabetes & Obesity at Eli Lilly and Co (NYSE:LLY), is set to retire at the end of this...
October 4, 2023, 8:34 am
Karuna therapeutics to present data from the emergent program evaluating karxt in schizophrenia at the 36th european college of neuropsychopharmacology (ecnp) congress
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven t...
October 4, 2023, 6:30 am
Sanofi to co-develop teva pharmaceutical's colitis, crohn's drug
Teva pharmaceutical Industries said on Wednesday it will collaborate with French drugmaker Sanofi to co...
October 4, 2023, 3:15 am
Io biotech announces three poster presentations at the society for immunotherapy of cancer’s (sitc) 38th annual meeting
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...
October 3, 2023, 8:30 pm
Rosen, a globally recognized law firm, encourages infinity pharmaceuticals, inc. investors to secure counsel before important october 16 deadline in securities class action – infi
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 3, 2023, 7:36 pm
Why eli lilly stock was looking sickly today
The pharmaceutical giant signed a deal to acquire cancer therapy developer Biopharma Global. Its asset-...
October 3, 2023, 6:33 pm
Takeda's dengue vaccine gets who group's recommendation
American depositary receipts of Takeda pharmaceutical Co. 4502, -1.79% TAK, -2.16% rose more than 1% in...
October 3, 2023, 5:36 pm
Novartis positioning is now best-suited for long-term gains and returns after spin-off, says ceo
Novartis CEO Vas Narasimhan joins 'Squawk on the Street' to discuss the company's new spin-off Sandoz, what a pure-play core ...
October 3, 2023, 12:08 pm
Eli lilly buys point biopharma to boost its cancer-fighting therapies
Shares of POINT Biopharma Global (PNT) skyrocketed over 80% in early trading on Tuesday after Eli Lilly (LLY) agreed to buy the radio...
October 3, 2023, 12:00 pm
Are medical stocks lagging exact sciences (exas) this year?
Here is how Exact Sciences (EXAS) and Anebulo pharmaceuticals, Inc. (ANEB) have performed compared to t...
October 3, 2023, 11:16 am
Navigating acumen's alzheimer's risk and reward
Acumen pharmaceuticals' ACU193 shows promise as a potential treatment for early-stage Alzheimer's Disea...
October 3, 2023, 11:03 am
Point biopharma shares storm ahead 84% after eli lily's $1.4bn bid
Shares in Point Biopharma Global jumped 84% following the announcement that pharmaceutical giant Eli Li...
October 3, 2023, 9:05 am